Cargando…

A review of the genome, epidemiology, clinical features, prevention, and treatment scenario of COVID-19: Bangladesh aspects

BACKGROUND: The ongoing acute respiratory disease pandemic termed COVID-19 caused by a newly emerged coronavirus has jeopardized the world’s health and economic sectors. As of 20 July 2020, the virus now known as SARS-CoV-2 has already infected more than 14 million individuals and killed 612,815 pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Al Noman, Abdullah, Islam, Md. Shofiqul, Sana, Samiron, Mondal, Prapti, Meem, Rima Islam, Rana, Sohel, Mondol, Debashish, Sana, Manoshi, Hossain, Sheikh I., Joarder, Taufique, Mazumder, Kishor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844806/
http://dx.doi.org/10.1186/s43168-021-00053-2
_version_ 1783644427378491392
author Al Noman, Abdullah
Islam, Md. Shofiqul
Sana, Samiron
Mondal, Prapti
Meem, Rima Islam
Rana, Sohel
Mondol, Debashish
Sana, Manoshi
Hossain, Sheikh I.
Joarder, Taufique
Mazumder, Kishor
author_facet Al Noman, Abdullah
Islam, Md. Shofiqul
Sana, Samiron
Mondal, Prapti
Meem, Rima Islam
Rana, Sohel
Mondol, Debashish
Sana, Manoshi
Hossain, Sheikh I.
Joarder, Taufique
Mazumder, Kishor
author_sort Al Noman, Abdullah
collection PubMed
description BACKGROUND: The ongoing acute respiratory disease pandemic termed COVID-19 caused by a newly emerged coronavirus has jeopardized the world’s health and economic sectors. As of 20 July 2020, the virus now known as SARS-CoV-2 has already infected more than 14 million individuals and killed 612,815 patients with a mortality rate of 4.12% around the world regardless of age, gender, and race. MAIN BODY: Bangladesh has become one of its worst sufferers, with 207,453 infected people and 2668 related deaths with a mortality rate of 1.29% until 20 July 2020. More than 50% of COVID-19 patients in Bangladesh are aged between 21 and 40, but elderly people aged more than 60 have the highest mortality rate (44.7%). Male individuals are also more susceptible to the virus than females and consist of 71% and 79% among the infected and deceased patients, respectively. The most prevalent clinical features following the virus incubation period are fever, fatigue, and dry cough. A phylogenetic analysis study elucidated that the virus strain found in the country has 9 single-nucleotide variants, mostly in the ORF1ab gene, and a sequence containing 3 successive variants in the N protein, which reflects a weaker strain of SARS-CoV-2, implicating a possibility of its lower mortality rate. Another investigation of 184 genome samples of SARS-CoV-2 across the country implicated a close homology with a European haplotype of SARS-CoV-2. The country has also joined the race of vaccine development and started phase III clinical trials of a candidate vaccine developed by Sinovac Research and Development Co Ltd, China. CONCLUSION: Bangladesh, as a developing country, still struggles with the pandemic and needs to scale up its response operation and improve healthcare facilities such as testing capacity, institutional quarantine, and isolation centers and promote awareness. Preventive measures such as strict lockdown, social distancing, and boosting the existing immune system are thus considered the only contrivances.
format Online
Article
Text
id pubmed-7844806
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-78448062021-01-29 A review of the genome, epidemiology, clinical features, prevention, and treatment scenario of COVID-19: Bangladesh aspects Al Noman, Abdullah Islam, Md. Shofiqul Sana, Samiron Mondal, Prapti Meem, Rima Islam Rana, Sohel Mondol, Debashish Sana, Manoshi Hossain, Sheikh I. Joarder, Taufique Mazumder, Kishor Egypt J Bronchol Reviews BACKGROUND: The ongoing acute respiratory disease pandemic termed COVID-19 caused by a newly emerged coronavirus has jeopardized the world’s health and economic sectors. As of 20 July 2020, the virus now known as SARS-CoV-2 has already infected more than 14 million individuals and killed 612,815 patients with a mortality rate of 4.12% around the world regardless of age, gender, and race. MAIN BODY: Bangladesh has become one of its worst sufferers, with 207,453 infected people and 2668 related deaths with a mortality rate of 1.29% until 20 July 2020. More than 50% of COVID-19 patients in Bangladesh are aged between 21 and 40, but elderly people aged more than 60 have the highest mortality rate (44.7%). Male individuals are also more susceptible to the virus than females and consist of 71% and 79% among the infected and deceased patients, respectively. The most prevalent clinical features following the virus incubation period are fever, fatigue, and dry cough. A phylogenetic analysis study elucidated that the virus strain found in the country has 9 single-nucleotide variants, mostly in the ORF1ab gene, and a sequence containing 3 successive variants in the N protein, which reflects a weaker strain of SARS-CoV-2, implicating a possibility of its lower mortality rate. Another investigation of 184 genome samples of SARS-CoV-2 across the country implicated a close homology with a European haplotype of SARS-CoV-2. The country has also joined the race of vaccine development and started phase III clinical trials of a candidate vaccine developed by Sinovac Research and Development Co Ltd, China. CONCLUSION: Bangladesh, as a developing country, still struggles with the pandemic and needs to scale up its response operation and improve healthcare facilities such as testing capacity, institutional quarantine, and isolation centers and promote awareness. Preventive measures such as strict lockdown, social distancing, and boosting the existing immune system are thus considered the only contrivances. Springer Berlin Heidelberg 2021-01-29 2021 /pmc/articles/PMC7844806/ http://dx.doi.org/10.1186/s43168-021-00053-2 Text en © The Author(s) 2021, corrected publication 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Reviews
Al Noman, Abdullah
Islam, Md. Shofiqul
Sana, Samiron
Mondal, Prapti
Meem, Rima Islam
Rana, Sohel
Mondol, Debashish
Sana, Manoshi
Hossain, Sheikh I.
Joarder, Taufique
Mazumder, Kishor
A review of the genome, epidemiology, clinical features, prevention, and treatment scenario of COVID-19: Bangladesh aspects
title A review of the genome, epidemiology, clinical features, prevention, and treatment scenario of COVID-19: Bangladesh aspects
title_full A review of the genome, epidemiology, clinical features, prevention, and treatment scenario of COVID-19: Bangladesh aspects
title_fullStr A review of the genome, epidemiology, clinical features, prevention, and treatment scenario of COVID-19: Bangladesh aspects
title_full_unstemmed A review of the genome, epidemiology, clinical features, prevention, and treatment scenario of COVID-19: Bangladesh aspects
title_short A review of the genome, epidemiology, clinical features, prevention, and treatment scenario of COVID-19: Bangladesh aspects
title_sort review of the genome, epidemiology, clinical features, prevention, and treatment scenario of covid-19: bangladesh aspects
topic Reviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844806/
http://dx.doi.org/10.1186/s43168-021-00053-2
work_keys_str_mv AT alnomanabdullah areviewofthegenomeepidemiologyclinicalfeaturespreventionandtreatmentscenarioofcovid19bangladeshaspects
AT islammdshofiqul areviewofthegenomeepidemiologyclinicalfeaturespreventionandtreatmentscenarioofcovid19bangladeshaspects
AT sanasamiron areviewofthegenomeepidemiologyclinicalfeaturespreventionandtreatmentscenarioofcovid19bangladeshaspects
AT mondalprapti areviewofthegenomeepidemiologyclinicalfeaturespreventionandtreatmentscenarioofcovid19bangladeshaspects
AT meemrimaislam areviewofthegenomeepidemiologyclinicalfeaturespreventionandtreatmentscenarioofcovid19bangladeshaspects
AT ranasohel areviewofthegenomeepidemiologyclinicalfeaturespreventionandtreatmentscenarioofcovid19bangladeshaspects
AT mondoldebashish areviewofthegenomeepidemiologyclinicalfeaturespreventionandtreatmentscenarioofcovid19bangladeshaspects
AT sanamanoshi areviewofthegenomeepidemiologyclinicalfeaturespreventionandtreatmentscenarioofcovid19bangladeshaspects
AT hossainsheikhi areviewofthegenomeepidemiologyclinicalfeaturespreventionandtreatmentscenarioofcovid19bangladeshaspects
AT joardertaufique areviewofthegenomeepidemiologyclinicalfeaturespreventionandtreatmentscenarioofcovid19bangladeshaspects
AT mazumderkishor areviewofthegenomeepidemiologyclinicalfeaturespreventionandtreatmentscenarioofcovid19bangladeshaspects
AT alnomanabdullah reviewofthegenomeepidemiologyclinicalfeaturespreventionandtreatmentscenarioofcovid19bangladeshaspects
AT islammdshofiqul reviewofthegenomeepidemiologyclinicalfeaturespreventionandtreatmentscenarioofcovid19bangladeshaspects
AT sanasamiron reviewofthegenomeepidemiologyclinicalfeaturespreventionandtreatmentscenarioofcovid19bangladeshaspects
AT mondalprapti reviewofthegenomeepidemiologyclinicalfeaturespreventionandtreatmentscenarioofcovid19bangladeshaspects
AT meemrimaislam reviewofthegenomeepidemiologyclinicalfeaturespreventionandtreatmentscenarioofcovid19bangladeshaspects
AT ranasohel reviewofthegenomeepidemiologyclinicalfeaturespreventionandtreatmentscenarioofcovid19bangladeshaspects
AT mondoldebashish reviewofthegenomeepidemiologyclinicalfeaturespreventionandtreatmentscenarioofcovid19bangladeshaspects
AT sanamanoshi reviewofthegenomeepidemiologyclinicalfeaturespreventionandtreatmentscenarioofcovid19bangladeshaspects
AT hossainsheikhi reviewofthegenomeepidemiologyclinicalfeaturespreventionandtreatmentscenarioofcovid19bangladeshaspects
AT joardertaufique reviewofthegenomeepidemiologyclinicalfeaturespreventionandtreatmentscenarioofcovid19bangladeshaspects
AT mazumderkishor reviewofthegenomeepidemiologyclinicalfeaturespreventionandtreatmentscenarioofcovid19bangladeshaspects